MiniMed Group, Inc. Common Stock (MMED)
Northridge, CA, US
MiniMed Group, Inc. specializes in designing, producing, and distributing a broad spectrum of medical technologies and solutions aimed at effective diabetes management. The company's diverse portfolio features essential tools like insulin pumps, continuous glucose monitoring (CGM) systems, infusion sets, specialized software platforms, and various supplementary accessories. These innovations are crafted to enable both patients and healthcare providers to accurately monitor and precisely regulate blood glucose levels. The enterprise was established in 1983 by Alfred E. Mann and is currently headquartered in Northridge, California.
No mergers or acquisitions recorded for this company.
| Indicator | 1D | 1W | 2W | 3W | 1M |
|---|
Day Score & sub-scores
Statistical fingerprint & regime detail
Conditional historical analysis
Customize analysis (advanced)
Revenue flow
Revenue by geography
Revenue by segment
Revenue composition
By product
By geography
Income Statement
Balance Sheet
Cash Flow Statement
Key Metrics
Financial Ratios
Employees
Financial Growth (CAGR)
Market Data
| Metric |
Apr 2025 actual |
Apr 2026 6 Rev. Ana. 3 EPS Ana. |
Apr 2027 9 Rev. Ana. 6 EPS Ana. |
Apr 2028 9 Rev. Ana. 6 EPS Ana. |
Apr 2029 6 Rev. Ana. 3 EPS Ana. |
Apr 2030 3 Rev. Ana. 1 EPS Ana. |
Apr 2031 3 Rev. Ana. 1 EPS Ana. |
|---|---|---|---|---|---|---|---|
| Revenue |
2.72B
est: 2.89B (-5.9%)
|
3.09B
3.08B – 3.10B
+7.0% YoY
|
3.42B
3.41B – 3.45B
+10.9% YoY
|
3.70B
3.66B – 3.74B
+8.0% YoY
|
4.06B
4.06B – 4.06B
+9.9% YoY
|
4.54B
4.51B – 4.57B
+11.6% YoY
|
4.96B
4.93B – 4.99B
+9.3% YoY
|
| EBITDA |
107.00M
est: 69.61M (+53.7%)
|
74.47M
74.23M – 74.71M
+7.0% YoY
|
82.57M
82.33M – 83.16M
+10.9% YoY
|
89.21M
88.25M – 90.17M
+8.0% YoY
|
98.03M
98.03M – 98.03M
+9.9% YoY
|
109.43M
108.72M – 110.21M
+11.6% YoY
|
119.61M
118.83M – 120.46M
+9.3% YoY
|
| EBIT |
-36.00M
est: -43.05M (+16.4%)
|
-46.06M
-46.21M – -45.91M
-7.0% YoY
|
-51.07M
-51.43M – -50.92M
-10.9% YoY
|
-55.17M
-55.77M – -54.58M
-8.0% YoY
|
-60.63M
-60.63M – -60.63M
-9.9% YoY
|
-67.68M
-68.16M – -67.24M
-11.6% YoY
|
-73.97M
-74.50M – -73.50M
-9.3% YoY
|
| Net Income |
-250.00M
|
87.67M
61.37M – 113.97M
|
172.07M
150.62M – 190.79M
+96.3% YoY
|
167.46M
115.56M – 198.46M
-2.7% YoY
|
437.27M
394.95M – 479.59M
+161.1% YoY
|
595.80M
590.79M – 601.33M
+36.3% YoY
|
808.29M
801.49M – 815.78M
+35.7% YoY
|
| SGA |
1.13B
est: 1.19B (-5.2%)
|
1.28B
1.27B – 1.28B
+7.0% YoY
|
1.42B
1.41B – 1.43B
+10.9% YoY
|
1.53B
1.51B – 1.55B
+8.0% YoY
|
1.68B
1.68B – 1.68B
+9.9% YoY
|
1.88B
1.86B – 1.89B
+11.6% YoY
|
2.05B
2.04B – 2.06B
+9.3% YoY
|
| EPS |
-0.89
|
0.33
0.24 – 0.44
|
0.68
0.59 – 0.74
+104.4% YoY
|
0.66
0.45 – 0.77
-2.8% YoY
|
1.75
1.54 – 1.87
+166.1% YoY
|
2.32
2.30 – 2.34
+33.1% YoY
|
3.15
3.12 – 3.18
+35.7% YoY
|
Owner Earnings
Owner's Earnings history not available.
Ownership Overview
Ownership breakdown not available.
No beneficial ownership filings recorded.
Institutional Activity (13F)
Institutional history not available.
Top holders not available.
ETF Ownership
| # | ETF | Weight | Est. AUM exposure | TER |
|---|---|---|---|---|
| 1 | Ballast Small/Mid Cap ETF MGMT | 1.49% | 2.24M | 1.10% |
| 2 | First Trust US Equity Opportunities ETF FPX | 0.35% | 5.53M | 0.57% |
| 3 | Goldman Sachs Innovate Equity ETF GINN | 0.16% | 343.9K | 0.50% |
| 4 | First Trust US Equity Opportunities UCITS ETF FPX.L | 0.09% | 16.4K | 0.65% |
| 5 | iShares Russell 2000 Value ETF IWN | 0.03% | 4.06M | 0.24% |
| 6 | Franklin U.S. Small Cap Multifactor Index ETF FLQS | 0.03% | 14.1K | 0.35% |
| 7 | Goldman Sachs ActiveBeta U.S. Small Cap Equity ETF GSSC | 0.02% | 221.2K | 0.20% |
| 8 | Invesco Russell 2000 Dynamic Multifactor ETF OMFS | 0.02% | 56.8K | 0.39% |
| 9 | State Street SPDR Russell 2000 U.S. Small Cap UCITS ETF (Acc) R2US.L | 0.02% | 899.9K | 0.30% |
| 10 | iShares Russell 2000 BuyWrite ETF IWMW | 0.01% | 8.0K | 0.39% |
Insider Activity
No insider activity available.
Insider history not available.
No recent insider transactions.
No data available for this company.
No Senate trading activity found for this company.
No House trading activity found for this company.
Share your view on this stock and instantly see how the community has voted over the last 6 months.
Community Opinion for MMED
Short-term intention
Target Price Distribution
These are community opinions and do not constitute buy or sell advice to act on. The results shown are based on aggregated opinions and are not an investment recommendation, nor do they intend to influence any investment decision.

MSCI World Index (MSC)
NASDAQ Composite (NASDAQ)
FTSE China A50 Index (FGI)
STOXX Europe 600 (SIX)
Nikkei 300 (OSA)
NIFTY 50 (NSE)
DAX Performance Index (XETRA)
FTSE 100 (FGI)
CAC 40 (EURONEXT)
